Kamilla W Miskowiakt et al. investigated the impact of combining electroconvulsive therapy with erythropoietin (EPO) on enhancing cognitive performance in patients with depression and mood disorders (Miskowiak et al., 2024). The gene discussed is EPO; the disease is depressive symptom measurement.